Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Hearing loss and tinnitus—are funders and industry listening?

Nature Biotechnology volume 31, pages 972–974 (2013)Cite this article

Subjects

To the Editor:

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Funding and publication in diabetes, hearing and tinnitus research.

References

  1. Sheridan, C. Nat. Biotechnol. 31, 575–576 (2013).

    Article  CAS  Google Scholar 

  2. Salomon, J.A. et al. Lancet 380, 2129–2143 (2012).

    Article  Google Scholar 

  3. Anonymous. Lancet 378, 99 (2011).

  4. King, H., Aubert, R.E. & Herman, W.H. Diabetes Care 21, 1414–1431 (1998).

    Article  CAS  Google Scholar 

  5. Nolan, C.J., Damm, P. & Prentki, M. Lancet 378, 169–181 (2011).

    Article  Google Scholar 

  6. Langguth, B. & Elgoyhen, A.B. Expert Opin. Pharmacother. 13, 2495–2509 (2012).

    Article  CAS  Google Scholar 

  7. Shargorodsky, J., Curhan, G.C. & Farwell, W.R. Am. J. Med. 123, 711–718 (2010).

    Article  Google Scholar 

  8. Friberg, E., Jansson, C., Mittendorfer-Rutz, E., Rosenhall, U. & Alexanderson, K. PLoS ONE 7, e29966 (2012).

    Article  CAS  Google Scholar 

  9. Hall, D.A. et al. BMC Health Serv. Res. 11, 302 (2011).

    Article  Google Scholar 

  10. Baguley, D., McFerran, D. & Hall, D. Tinnitus. Lancet doi:10.1016/S0140-6736(13)60142-7 (2 July 2013).

  11. Basile, A.S. et al. Nat. Med. 2, 1338–1343 (1996).

    Article  CAS  Google Scholar 

  12. Duan, M., Agerman, K., Ernfors, P. & Canlon, B. Proc. Natl. Acad. Sci. USA 97, 7597–7602 (2000).

    Article  CAS  Google Scholar 

  13. Puel, J.L., Pujol, R., Tribillac, F., Ladrech, S. & Eybalin, M. J. Comp. Neurol. 341, 241–256 (1994).

    Article  CAS  Google Scholar 

  14. Ruel, J., Bobbin, R.P., Vidal, D., Pujol, R. & Puel, J.L. Neuropharmacology 39, 1959–1973 (2000).

    Article  CAS  Google Scholar 

  15. Guitton, M.J. et al. J. Neurosci. 23, 3944–3952 (2003).

    Article  CAS  Google Scholar 

  16. Ruel, J. et al. J. Neurosci. 28, 7313–7323 (2008).

    Article  CAS  Google Scholar 

  17. Glowatzki, E. & Fuchs, P.A. Nat. Neurosci. 5, 147–154 (2002).

    Article  CAS  Google Scholar 

  18. Keen, E.C. & Hudspeth, A.J. Proc. Natl. Acad. Sci. USA 103, 5537–5542 (2006).

    Article  CAS  Google Scholar 

  19. Engineer, N.D. et al. Nature 470, 101–104 (2011).

    Article  Google Scholar 

  20. Middleton, J.W. et al. Proc. Natl. Acad. Sci. USA 108, 7601–7606 (2011).

    Article  CAS  Google Scholar 

  21. Yang, S., Weiner, B.D., Zhang, L.S., Cho, S.J. & Bao, S. Proc. Natl. Acad. Sci. USA 108, 14974–14979 (2011).

    Article  CAS  Google Scholar 

  22. Li, S., Choi, V. & Tzounopoulos, T. Proc. Natl. Acad. Sci. USA 110, 9980–9985 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank all organizations mentioned in this article that shared their expenditures, as well as the Hudspeth laboratory for invaluable support. C.R.C. is a recipient of post-doctoral fellowships from the Swiss National Science Foundation (SNF) nþ PBGEP3-125837 and the Schweizerischen Stiftung für medizinisch-biologische Stipendien (SSMBS) nþ PASMP3-136979 and has received funding from the Wenner Gren, Lars Hiertas Minne, Magnus Bergvalls Stiftelserna and Tysta Skolan. B.C. has received funding from the Vetenskapsrådet (VR), Forskningsrådet för arbetsliv och socialvetenskap (FAS), Karolinska Institutet and Tysta Skolan. B.L. has received research funding from the Tinnitus Research Initiative (TRI), the American Tinnitus Association (ATA), the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium für Bildung und Forschung (BMBF), AztraZeneca and Cerbomed. This article reflects the authors' personal opinions and not those of the cited organizations.

Author information

Authors and Affiliations

  1. Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

    Christopher R Cederroth & Barbara Canlon

  2. Department of Psychiatry and Psychotherapy, University of Regensburg, and Tinnitus Research Initiative, Regensburg, Germany

    Berthold Langguth

Authors
  1. Christopher R Cederroth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Canlon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Berthold Langguth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher R Cederroth.

Ethics declarations

Competing interests

B.L. has received honoraria and speakers' fee from ANM, AztraZeneca, Autifony, Lundbeck, Merz, Magventure, Novartis, Pfizer and Servier, and travel and accommodation payments from Lilly, Servier and Pfizer. B.L. is a member of the executive board of the Tinnitus Research Initiative.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cederroth, C., Canlon, B. & Langguth, B. Hearing loss and tinnitus—are funders and industry listening?. Nat Biotechnol 31, 972–974 (2013). https://doi.org/10.1038/nbt.2736

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2736

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing